Massey pilot study could help identify breast cancer patients who would benefit from preoperative hormone therapy as alternative to chemotherapy
Preliminary findings from a pilot study led by VCU Massey Cancer Center suggest that it may be possible to use genetic testing to identify more breast cancer patients who would benefit from hormone therapy as an alternative to chemotherapy. Hormone therapy, also known as endocrine therapy, lowers estrogen levels or completely restricts estrogen from acting upon breast cancer cells, and its increased use could spare patients from the treatment side effects of chemotherapy and allow for more breast-conserving surgeries.
Massey researcher working to develop novel nanotherapeutics for lung cancer
Scientist Sandro da Rocha, Ph.D., hopes to eventually develop novel drugs that can be used as a primary or adjuvant therapy for multiple forms of lung cancer. A member of VCU Massey Cancer Center’s Developmental Therapeutics research program since March 2016, da Rocha has centered his research on designing nanotherapeutics that can target cancer cells with improved efficacy and decreased toxicity.
Massive community art print honoring locals affected by cancer to be unveiled
A world record-setting print created in September 2016 honoring community members affected by cancer will be unveiled in Richmond, Virginia. This will be the first time the print is on display for public view.
Devanand Sarkar named Massey's associate director for education and training
Massey researcher Devanand Sarkar, M.B.B.S., Ph.D., has been appointed as the associate director for education and training at VCU Massey Cancer Center. Sarkar holds the Harrison Foundation Distinguished Professorship in Cancer Research at Massey and is a member of Massey’s Cancer Molecular Genetics research program. He is also an associate professor in the Department of Human and Molecular Genetics at the VCU School of Medicine and associate scientific director, Cancer Therapeutics, at the VCU Institute of Molecular Medicine. Additionally, he co-directs the Cancer and Molecular Medicine Ph.D. program of the VCU Center for Clinical and Translational Research.
New patient-centered program at VCU Massey Cancer Center raises the bar for pancreatic cancer care
VCU Massey Cancer Center recently opened its Pancreas and Biliary Neoplasm Program for patients like Tuppince. The program is the first of its kind in the Richmond area, and it aims to reduce treatment delays and improve outcomes through a multi-disciplinary, patient-centered approach.